Mesoblast Limited has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback